Atara Biotherapeutics (ATRA) Inventory (2022 - 2024)

Atara Biotherapeutics (ATRA) has reported Inventory for 3 consecutive years, with $10.7 million the latest figure, recorded in Q4 2024.

• For the quarter ending Q4 2024, Inventory rose 9.78% year-over-year to $10.7 million; the trailing twelve-month figure through Dec 2024 stood at $10.7 million (up 9.78% YoY), and the FY2024 full-year result was $10.7 million, up 9.78% from the prior year.
• Inventory declined to $10.7 million in Q4 2024 per ATRA's latest filing, from $14.0 million in the prior quarter.
• Across five years, Inventory topped out at $18.7 million in Q2 2024 and bottomed at $1.6 million in Q4 2022.
• Historically, Inventory has averaged $10.1 million across 3 years, with a median of $9.7 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Inventory jumped 511.98% in 2023, then gained 9.78% in 2024.
• Over 3 years, Inventory stood at $1.6 million in 2022, then surged by 511.98% to $9.7 million in 2023, then climbed by 9.78% to $10.7 million in 2024.
• According to Business Quant data, Inventory over the past three periods registered $10.7 million, $14.0 million, and $18.7 million for Q4 2024, Q3 2024, and Q2 2024 respectively.